Search research articles
Contact Us
Filters
Showing results (161-170 of 175) with videos related to
Page
of 18
Sort By:
Biorxiv : the Preprint Server for Biology
|
September 2, 2025
Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma
Nikhil Chilakapati, Bonell Patiño-Escobar, Emily Y Chen, et al.
Nature Communications
|
April 23, 2025
Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia
Juwita Werner, Alex G Lee, Chujing Zhang, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 5, 2023
Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma
Francesca Ratti, Rebecca Marino, Paolo Muiesan, et al.
Nature Communications
|
July 15, 2022
The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance
Ian D Ferguson, Bonell Patiño-Escobar, Sami T Tuomivaara, et al.
Biorxiv : the Preprint Server for Biology
|
October 31, 2023
Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens
Darwin W Kwok, Nicholas O Stevers, Takahide Nejo, et al.
Nature
|
February 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigens
Darwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria, et al.
Journal for Immunotherapy of Cancer
|
December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
Signal Transduction and Targeted Therapy
|
August 17, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts
Josep Amengual, Ester Gonzalez-Sanchez, Mariana Yáñez-Bartolome, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells
Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 175) with videos related to
Sort By:
Page
of 18
Biorxiv : the Preprint Server for Biology
|
September 2, 2025
Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma
Nikhil Chilakapati, Bonell Patiño-Escobar, Emily Y Chen, et al.
Nature Communications
|
April 23, 2025
Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia
Juwita Werner, Alex G Lee, Chujing Zhang, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 5, 2023
Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma
Francesca Ratti, Rebecca Marino, Paolo Muiesan, et al.
Nature Communications
|
July 15, 2022
The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance
Ian D Ferguson, Bonell Patiño-Escobar, Sami T Tuomivaara, et al.
Biorxiv : the Preprint Server for Biology
|
October 31, 2023
Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens
Darwin W Kwok, Nicholas O Stevers, Takahide Nejo, et al.
Nature
|
February 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigens
Darwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria, et al.
Journal for Immunotherapy of Cancer
|
December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
Signal Transduction and Targeted Therapy
|
August 17, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts
Josep Amengual, Ester Gonzalez-Sanchez, Mariana Yáñez-Bartolome, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells
Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Page
of 18